Vela Diagnostics Receives EUA for Zika MDx

Sep 26, 2016

|

A previous version of this story incorrectly stated the Vela Zika test workflow uses Qiagen's Rotor-Gene Q platform. It uses the Applied Biosystems 7500 Fast Dx Real-Time PCR platform.

NEW YORK (GenomeWeb) – A Zika assay from Singapore-based molecular diagnostics firm Vela Diagnostics has received Emergency Use Authorization from the US Food and Drug Administration.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Vela Diagnostics Receives EUA for Zika MDx

To read the full story....

Breaking News

FDA Issues Emergency Use Authorization for University of Nebraska Medical Center Coronavirus Test

Oxford Immunotec Shares Rise Sharply on Report of $400M Acquisition Offer

Medix Biochemica Acquires US Firms EastCoast Bio, Biostride

HHS Releases Data Reporting Guidance for Labs Performing SARS-CoV-2 Testing

Opti Medical Systems Gets CE Mark for Coronavirus Test Kit

AACC Revises Guidance on Management of Point-of-Care Testing

Featured White Papers

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

What's Popular?

Beset by COVID-19 Pandemic, Europe Searches for Right Test Mix for Diagnosis, Surveillance

FDA Issues Emergency Use Authorizations for Gravity Diagnostics, Aspirus, CSI Coronavirus Tests

Opti Medical Systems Gets CE Mark for Coronavirus Test Kit

Mobidiag Receives CE Mark for Two PCR SARS-CoV-2 Tests

FDA Adds At-Home Self-Collection Template to SARS-CoV-2 Emergency Use Authorization Guidance

Sponsorships